Loading...

Do Patient Characteristics Moderate the Effect of Extended-Release Naltrexone (XR-NTX) for Opioid Use Disorder?

BACKGROUND: Extended release naltrexone (XR-NTX) injected intramuscularly monthly has been shown to reduce relapse in persons with opioid use disorder. Baseline factors, including patients’ demographics, comorbidities and lifestyle, may help identify patients who will benefit most or least from XR-N...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Subst Abuse Treat
Main Authors: Friedmann, Peter D., Wilson, Donna, Nunes, Edward V., Hoskinson, Randall, Lee, Joshua D., Gordon, Michael, Murphy, Sean M., Bonnie, Richard J., Chen, Donna T., Boney, Tamara Y., O’Brien, Charles P.
Format: Artigo
Sprog:Inglês
Udgivet: 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5565721/
https://ncbi.nlm.nih.gov/pubmed/28236511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2017.01.018
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!